Federated Hermes’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-26
| Closed | -$488 | – | 2042 |
|
|
2023
Q3 | $488 | Sell |
26
-39
| -60% | -$732 | ﹤0.01% | 2042 |
|
|
2023
Q2 | $1.58K | Hold |
65
| – | – | ﹤0.01% | 2002 |
|
|
2023
Q1 | $1.42K | Sell |
65
-62
| -49% | -$1.35K | ﹤0.01% | 2026 |
|
|
2022
Q4 | $3.03K | Buy |
127
+46
| +57% | +$1.1K | ﹤0.01% | 1974 |
|
|
2022
Q3 | $2K | Buy |
+81
| New | +$2K | ﹤0.01% | 1956 |
|
|
2022
Q2 | – | Sell |
-59,000
| Closed | -$3.17M | – | 2135 |
|
|
2022
Q1 | $3.17M | Hold |
59,000
| – | – | 0.01% | 896 |
|
|
2021
Q4 | $17.5M | Hold |
59,000
| – | – | 0.03% | 520 |
|
|
2021
Q3 | $22.9M | Buy |
59,000
+39,000
| +195% | +$15.1M | 0.04% | 442 |
|
|
2021
Q2 | $10.2M | Hold |
20,000
| – | – | 0.02% | 652 |
|
|
2021
Q1 | $11.4M | Hold |
20,000
| – | – | 0.02% | 629 |
|
|
2020
Q4 | $13.8M | Buy |
+20,000
| New | +$13.8M | 0.03% | 558 |
|